Skip to main content

Mayo Clinic

ServiceRochester, MN, USA· One of 2063 Service companies tracked by AMPulse

Provides in-house, patient-specific 3D printing services for surgical planning, anatomical models, and medical devices, reducing surgical time by up to 25% and improving outcomes.

CEO / Founder
Gianrico Farrugia
Team Size
10000+
Stage
Active
Total Funding
$232.8M
Latest Round
Grant

Technology & Products

Key Products

Licensing agreements for intellectual property (patents, know-how), technology funding, product development, and a portfolio of market-leading products and services through Mayo Clinic Global Business Solutions.

Technological Advantage

Proprietary workflows for FDA-compliant medical 3D printing, leveraging multi-material capabilities (polymers, metals) and bioprinting for tissue models, with defensible IP from 4,159 patents.

Differentiation

Value Proposition

Enables precise surgical planning with life-size anatomical models, cutting operative time by 20-25% and reducing complications, while offering on-demand production within hospital workflows for faster patient care.

How They Differentiate

Mayo Clinic differentiates itself through its patient-first philosophy, integrated care model, and a consistent emphasis on patient-centricity, which is novel in the healthcare industry. They also offer hospital-integrated, point-of-care 3D printing with direct clinical oversight for faster turnaround and higher customization.

Market & Competition

Target Customers

Surgeons, physicians, medical trainees, researchers, and patients requiring personalized medical models or devices.

Industry Verticals

Healthcare; Medical Devices; Education; Research

Competitors

Kaiser Permanente, Cleveland Clinic, MD Anderson Cancer Center

Growth & Milestones

Growth Metrics

Revenue grew to $17.9 billion in 2023, with 8.7% year-over-year increase; 3D printing operations expanded to serve multiple disciplines daily, with over 45 million people reached through Mayo Clinic Platform.

Major Milestones

2006: Started additive manufacturing for surgical aids; 2020: Added metal 3D printing with titanium unit; 2023: Launched Mayo Clinic Platform_Orchestrate for faster therapy development; 2025: Reported 12,400 new employees added

Notable Customers

Mayo Clinic patients and physicians; Healthcare clients via Mayo Clinic Laboratories (over 3,100)

https://www.mayoclinic.org

Why this company matters

Mayo Clinic provides in-house, patient-specific 3D printing services for surgical planning, anatomical models, and medical devices. Its point-of-care additive manufacturing facility operates 24/7 within a hospital setting, combining clinical expertise with real-time production to reduce surgical time by up to 25% and improve patient outcomes.

The core technology spans polymer material extrusion, SLA, and metal laser powder bed fusion, including a titanium unit added in 2020. Proprietary workflows support FDA-compliant medical 3D printing with multi-material capabilities, and bioprinting is used for tissue models. These capabilities are integrated directly into hospital workflows for faster turnaround than external service bureaus.

Target customers are surgeons, physicians, and medical trainees requiring personalized models or devices. Mayo Clinic serves its own patients and physicians, and extends reach to over 3,100 healthcare clients via Mayo Clinic Laboratories. Key partners include Materialise, Link3D, and Google for the Mayo Clinic Cloud platform.

Mayo Clinic's strategic moat lies in its integrated care model and defensible IP portfolio of over 4,000 patents, including licensing agreements for medical 3D printing know-how. Competition includes other large healthcare systems like Cleveland Clinic and Kaiser Permanente. The open question is whether point-of-care 3D printing can scale beyond flagship academic medical centers to community hospitals.